ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGY Allergy Therapeutics Plc

2.875
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.875 2.75 3.00 2.875 2.875 2.88 973,172 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 59.59M -43.07M -0.0090 -3.19 136.8M
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 2.88p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 0.85p to 3.80p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £136.80 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -3.19.

Allergy Therapeutics Share Discussion Threads

Showing 4726 to 4750 of 5000 messages
Chat Pages: 200  199  198  197  196  195  194  193  192  191  190  189  Older
DateSubjectAuthorDiscuss
23/6/2023
19:28
ZenI suggest you should read coins post again.Hi
jimmyloser
23/6/2023
19:09
They maybe Chinese private equity firm, but doesn't give them right to just ignore European FDI regulatory approvals. That is just not true.
zen12
23/6/2023
14:55
coinbase,
I have voted that excellent post UP.
There is no denying anything that you have written. If only for the hell of it, I will ride this one out.
jl

jimmyloser
23/6/2023
14:11
Jimmyloser, I wish I shared your optimism. I’ve been doing this for far too long and been burnt more times than I care to remember. I sold the last of my shares yesterday at a 93.67% loss and would urge you and others to look again before averaging down. Towards the beginning of last year there were very few reasons not to invest in Allergy Therapeutics, the science was sound, the company was in good financial health and the principle shareholders (Abbott being the largest) were top-notch. Since then it’s been a completely different story. In May of last year Nick Wykeman, the then CFO, stepped down for no reason and to date still hasn’t been permanently replaced. Four months later the company voluntarily paused production at the Freeman facility, crippling cashflow and falling foul of the terms of its agreement with NatWest. To plug the gap Southern Fox and ZQ Capital loaned the company 10 million with conditions to take it private in the event of the most minor of infringements. Then on the 28th December 2022 Scott Leinenweber, Abbott Vice President, Investor Relations, Licensing and Acquisitions, resigned as a Non-Executive Director. I can’t imagine that Scott is the sort of chap that would suffer fools gladly, nor would he have jumped ship if either he or Abbott believed in the company's ability to deliver value to shareholders. The bottom line is that Abbott, the worlds largest healthcare company, and River and Mercantile Asset Management, with 4.1 billion under management and a keen eye for biotechnology businesses, are largely out and an obscure Chinese private equity firm are in, subject to certain European FDI regulatory approvals none of which are nailed on. In conclusion I think that there is a very good chance that what was a brilliant little company will go bust or be taken private before the end of next month.
coinbase
23/6/2023
12:04
So, we now have a new financial category of investors emerging - 'certified investors'. Before long, their investment performance will be compared agaist benchmarks.
farmergeorge
23/6/2023
11:54
Ok, I need to be certified but I've just had a nibble
jpuff
23/6/2023
10:22
Perhaps you are right, hope is the only thing left here.
farmergeorge
23/6/2023
10:14
FG
Where have you been? It is the only one left to me lol.

jimmyloser
23/6/2023
10:00
jimmyloser, whilst I agree with you, keeping fingers crossed is not an investment strategy.
farmergeorge
23/6/2023
09:37
Becca, lol, we have seen better days, for now we will just have to wear out the worry beads and keep our fingers crossed.

Good luck.

jimmyloser
23/6/2023
09:23
We will see Jimmy dear. The funniest part starts right now.
beccasan
23/6/2023
08:52
Whilst I too believe that there is more to this than meets our eye. I do however believe that the management do know what they are doing, they have an admirable record of delivering compound growth, whilst also delivering innovation. They are guided by a blue chip NOMAD and I believe that these are the darkest days.
There is a huge market for their products once through the gate, and we are closer to opening that gate now, than we have ever been.
It has been a bad year for sure, but it will soon be behind us. USA, China and UK et al, all need what we are developing.
As someone said, park our emotion and see if we are still here and more relevantly, where we are share price wise come the autumn.
Companies have all sorts of reasons for selling as they do for buying.

impo

jimmyloser
23/6/2023
08:17
Clearly there is something we don't know that goes far beyond simple insane economic and financial management. I don't see any conspiracy or speculation. But that's not good news. I only see Chaos from a mediocre management that crosses over from top management to the top and the management of the various departments and affiliates. Chaos that is now cathartically expressing itself all together. This company therefore has no hope. The probability that at least one trial will be successful is close to absolute zero. Because the history of this company proves it. But even the slightest hope that it will succeed is not even remotely enough to reverse fate. A clinical study means nothing. It does not imply registration in a country, it does not imply commercial success of the product. Here is just a widespread and widely mismanaged company, products canceled by the regulatory authorities of the most important countries and something else that we mysteriously still don't know that intuitively is happening very seriously in one or more affiliates. River and Mercantile must have sold for very serious reasons. Something very serious. That should be better investigated and that sooner or later it will come out. The majority shareholders I don't think will want to invest again and I don't think anyone else will. I'll leave it to you to simply deduce what will happen if my assessment is correct.
beccasan
22/6/2023
15:56
It's game over here by looks of it
jpuff
22/6/2023
15:51
23mill dumped at 0.80p -
tomboyb
22/6/2023
15:23
Terminal 1
volsung
22/6/2023
15:09
Terminal?!
coinbase
22/6/2023
14:40
How they going to raise money though? It will probably end up being taken over by the majority shareholder and sadly you will be wiped out.
amishp67
22/6/2023
13:01
So you're currently getting counselling lol....never understood why some PIs waste time on these boards. Don't like, then move on plenty of other stocks requiring your great insight...that should add don't require counselling!
zen12
22/6/2023
12:48
Book me in :-)
jimmyloser
22/6/2023
12:37
Anyone who buys stocks like this needs counselling
volsung
22/6/2023
11:17
If the grass trials are as clearly expected a huge success and progress is being made on nuts, raising more money will be no problem. Consolidation beckons.

I am trying to believe that there is a master plan at play.

jimmyloser
22/6/2023
11:00
Its the 2nd part that is the killer -

More monies will be required later this year -

tomboyb
22/6/2023
10:35
Selling at any price it seems -
tomboyb
22/6/2023
10:23
River and Mercantile, the only non 'Insider' large scale investor, appears to be liquidating its stake, getting about 1.125p. This tells us that it has no confidence in the idea of waiting for the Open Offer at 1p and then taking its chances with a closely-held company with the current management still in charge. This is troubling as a) R&M is a professional investor and so better qualified to make this decision and b) it almost certainly has access to management and therefore better information than us.

The path ahead is treacherous. 1) the Open Offer might never happen (unless I missed it, the Insiders have yet to get FDI clearance; the board has failed to answer the question of who is managing this process and controlling the risks. If there is no clearance AGY is handed to the Insiders free, owing to the shameful terms of the loan agreement). 2) if the Open Offer does happen, the company will be closely held and "might" be run in the interests of the Insiders, especially as there is yet more funding required this year. This is another issue the board has declined to comment on.

That R&M made the decision to take a huge loss rather than 'follow its money' on the treacherous path is deeply concerning.

Any views?

1kckeith
Chat Pages: 200  199  198  197  196  195  194  193  192  191  190  189  Older

Your Recent History

Delayed Upgrade Clock